Alvotech (ALVO) News Today $8.96 +0.94 (+11.71%) As of 03:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Alvotech (NASDAQ:ALVO) Announces Earnings Results, Beats Estimates By $0.40 EPSAugust 16 at 10:24 PM | marketbeat.comAlvotech (NASDAQ:ALVO) Sees Strong Trading Volume - What's Next?August 16 at 11:42 AM | marketbeat.comAlvotech Second Quarter 2025 Earnings: Beats ExpectationsAugust 16 at 2:00 AM | finance.yahoo.comAlvotech (NASDAQ:ALVO) Shares Gap Up - Time to Buy?August 15 at 2:31 PM | marketbeat.comAlvotech (ALVO) Q2 2025 Earnings Call Highlights: Robust Product Revenue Growth Amid Licensing ...August 15 at 2:20 AM | gurufocus.comQ2 2025 Alvotech SA Earnings Call TranscriptAugust 14, 2025 | gurufocus.comAlvotech targets 50% U.S. Humira biosimilar market share by year-end as Q2 product revenues rise 77%August 14, 2025 | msn.comAlvotech (ALVO) Reports Strong Growth and Strategic Expansions in Q2 2025August 14, 2025 | gurufocus.comAlvotech (ALVO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comAlvotech 2025 Q2 - Results - Earnings Call PresentationAugust 14, 2025 | seekingalpha.comAlvotech Reports Strong H1 2025 Financials and Strategic PartnershipsAugust 14, 2025 | msn.comAlvotech Reports Results for the First Six Months of 2025 and Provides a Business UpdateAugust 13, 2025 | globenewswire.comAlvotech Reports Results for the First Six Months of 2025 and Provides a Business UpdateAugust 13, 2025 | globenewswire.com4ALVO : Alvotech's Earnings: A PreviewAugust 12, 2025 | benzinga.comAlvotech (ALVO) Expected to Announce Earnings on WednesdayAugust 11, 2025 | marketbeat.comWall Street week ahead: Investors eye inflation, retail sales, Trump-Putin meetAugust 11, 2025 | msn.comAlvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, ...August 6, 2025 | gurufocus.comAlvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, ...August 6, 2025 | gurufocus.comAlvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDTAugust 6, 2025 | globenewswire.comAlvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDTAugust 6, 2025 | globenewswire.comAlvotech Expands Partnerships and Strengthens Leadership Amid Regulatory ProgressJuly 28, 2025 | tipranks.comDr Reddy's Labs Q1 Results: Net profit rises just 1.4% YoY to ₹1,409 crore; revenue surges 11%July 24, 2025 | msn.comDr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License AgreementJuly 23, 2025 | insidermonkey.comAlvotech (NASDAQ:ALVO) Given New $14.00 Price Target at UBS GroupJuly 19, 2025 | marketbeat.comAlvotech (ALVO) Price Target Reduced by UBS, Potential Growth Ahead | ALVO Stock NewsJuly 18, 2025 | gurufocus.comAlvotech (ALVO) Announces Acquisition of Ivers-Lee GroupJuly 17, 2025 | finance.yahoo.comAlvotech (ALVO) Announces Acquisition of Ivers-Lee GroupJuly 16, 2025 | insidermonkey.comAlvotech: A Fast-Expanding Biosimilar ConcernJuly 11, 2025 | seekingalpha.comAlvotech Appoints New CFO Amidst Continued GrowthJuly 10, 2025 | tipranks.comAlvotech names veteran Linda Jónsdóttir finance chiefJuly 10, 2025 | msn.comAlvotech Appoints Linda Jónsdóttir as Chief Financial OfficerJuly 10, 2025 | quiverquant.comQAlvotech Appoints Linda Jónsdóttir as Chief Financial OfficerJuly 10, 2025 | globenewswire.comAlvotech Appoints Linda Jónsdóttir as Chief Financial OfficerJuly 10, 2025 | globenewswire.comAlvotech acquires Ivers-Lee GroupJuly 9, 2025 | msn.comWhy Is Alvotech Stock Trading Higher On Wednesday?July 9, 2025 | benzinga.comAlvotech expands biosimilars capabilities with Ivers-Lee acquisitionJuly 9, 2025 | finance.yahoo.comAlvotech Acquires Ivers-Lee to Boost Biosimilar Packaging CapacityJuly 9, 2025 | tipranks.comAlvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in SwitzerlandJuly 9, 2025 | globenewswire.comAlvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in SwitzerlandJuly 9, 2025 | globenewswire.comAlvotech (NASDAQ:ALVO) Stock Price Down 2.3% - Time to Sell?July 9, 2025 | marketbeat.comAlvotech (ALVO) Announces a Commercialization Agreement With Advanz PharmaJuly 7, 2025 | finance.yahoo.comAlvotech (ALVO) Announces a Commercialization Agreement With Advanz PharmaJuly 6, 2025 | insidermonkey.comAlvotech S.A. Reports Increase in Own Shares to 6.73%, Exceeding 5% Voting Rights ThresholdJuly 3, 2025 | quiverquant.comQNotification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuersJuly 3, 2025 | globenewswire.comAlvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) - MorningstarJuly 2, 2025 | morningstar.comMGranting of Stock Options and Vesting of Restricted Share UnitsJuly 1, 2025 | globenewswire.comAlvotech and Advanz Pharma Forge European Biosimilar AgreementJuly 1, 2025 | tipranks.comAlvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)July 1, 2025 | globenewswire.comAlvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)July 1, 2025 | globenewswire.comAlvotech’s Lenders Lower Interest on Senior Secured Term Loan FacilityJune 26, 2025 | uk.finance.yahoo.com Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address ALVO Media Mentions By Week ALVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVO News Sentiment▼0.780.65▲Average Medical News Sentiment ALVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVO Articles This Week▼175▲ALVO Articles Average Week Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRNA News Today VRNA News Today BBIO News Today BPMC News Today ELAN News Today ROIV News Today GRFS News Today LEGN News Today RVMD News Today RYTM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVO) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access